Diabetic Retinopathy and IGF-1 Gene Polymorphic Cytosine-Adenine Repeats in a Southern Indian Cohort
- 12 September 2007
- journal article
- Published by S. Karger AG in Ophthalmic Research
- Vol. 39 (5), 294-299
- https://doi.org/10.1159/000108124
Abstract
Background/Aims: Growth factors have been implicated in the pathogenesis of diabetic retinopathy (DR). IGF-1 is known to trigger a critical cascade of molecular events that initiate retinal angiogenesis. Increased vitreous IGF-1 levels have been correlated with the severity of ischemia-associated diabetic retinal neovascularization. In the present study, a cytosine-adenine (CA)n repeat in the promoter of the IGF-1 gene is studied for association with DR. Methods: A total of 127 patients with retinopathy (cases: DR+) and 81 patients without retinopathy (controls: DR–) who had type 2 diabetes were recruited for the study. Patients underwent detailed clinical examination and DR was graded based on stereoscopic digital fundus photographs. Frequencies of alleles and genotypes between the two groups were analyzed for significance using relevant statistical tests. (CA)17 and (CA)18 repeats were the more frequent alleles. Results: The frequency of the 18-repeat genotype was significantly higher in DR+ patients when compared to DR– patients and found to confer a 2.4 times (95% CI: 1.2–5.0) and 2.8 times (95% CI: 1.1–7.5) higher risk for developing DR and proliferative DR, respectively, when compared to <18-repeat genotypes. Conclusions: Our study suggests that the 18-repeat genotype is a susceptibility genotype for DR and its clinical severity in a Southern Indian cohort.Keywords
This publication has 17 references indexed in Scilit:
- Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes.Brazilian Journal of Medical and Biological Research, 2006
- An IGF-I Gene Polymorphism Modifies the Risk of Diabetic RetinopathyDiabetes, 2006
- An IGF-I promoter polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36BMC Endocrine Disorders, 2005
- Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration – a case reportGrowth Hormone & IGF Research, 2005
- Retinal neovascularization during treatment with IGF-1 for insulin resistance syndromeAlbrecht von Graefes Archiv für Ophthalmologie, 2005
- Sankara Nethralaya—Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN—DREAMS 1): Study Design and Research MethodologyOphthalmic Epidemiology, 2005
- Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic RetinopathyThe American Journal of Pathology, 2004
- A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levelsActa Endocrinologica, 2003
- Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control studyClinical Science, 2003
- An Alternative Method of Grading Diabetic RetinopathyOphthalmology, 1986